9:05am-9:25am: The Importance of the Gut: Perturbing Early Microbiota

Dr. Martin Blaser, Director, Center for Advanced Biotechnology and Medicine Rutgers University

9:30am-10:10am: Key Innovations: Microbiome Therapy

Angany, Dr. Guy Tropper, Co-Founder

IgGenix, Dr. Jessica Grossman, CEO

Mabylon, Niccolò Pengo, CSO

Revolo Biotherapeutics, Jonathan Rigby, CEO


10:15am-10:30am: Networking Break


10:30am-11:10am: Exposure Therapy

Aravax, Dr. Sara Prickett, Co-Founder & CSO

Clostrabio, Ritu Shah, CEO

Intrommune Therapeutics, Michael Nelson, CEO

Moonlight Therapeutics, Samir Patel, CEO

Ukko, Anat Binur, Co-Founder & CEO


11:10am-11:45am: How to Accelerate Investment in Food Allergy

Moderated by Andy Weissman, Managing Partner, Union Square Ventures

Dr. Evan Bedil, Head of Healthcare, Marathon Asset Management

Jonathan Fassberg, Vice Chairman - Healthcare Investment Banking, Oppenheimer & Co. Inc.

Buzzy Geduld, CEO, Cougar Capital


11:45am-12:45pm: Networking Lunch


12:45pm-1:00pm: mRNA Technology & Food Allergy

Dr. Drew Weissman, Director, Institute for RNA Innovation University of Pennsylvania

Dr. Marc Rothenberg, Director, Division of Allergy and Immunology Cincinnati Children's Hospital


1:00pm-1:15pm: Manipulating the Gut: Fecal Microbiota Transplant & Food Allergy (FMT)

Dr. Rima Rachid, Co-Director, Food Allergy Program Boston Children’s Hospital

1:15pm-2:15pm: Managing Life with Food Allergies: Diagnostics, Prevention, and Consumer Tech

Allergenis, Jim Garner, CEO

Allergy Amulet, Abi Barnes, CEO

Anjo.ai, Tal Golan, Co-Founder & CEO

Bryn Pharma, Sandy Loreaux, CEO

Kaléo, Ronald Gunn, President & CEO

Ready, Set, Food, Daniel Zakowski, CEO

Square Baby, Katie Thomson, CEO

2:15pm-3pm: Networking Session